We are live on
!
Find out more
Verition Fund Management Portfolio holdings
AUM
$15.4B
1-Year Est. Return
30.69%
This Fund
S&P 500
This Quarter
Est. Return
+2%
1 Year Est. Return
+30.69%
3 Year Est. Return
+85.73%
5 Year Est. Return
+92.38%
10 Year Est. Return
+282.97%
AUM
$7.23B
AUM Growth
+$828M
(+13%)
Cap. Flow
-$307M
Cap. Flow
% of AUM
-4.25%
Top 10 Holdings %
Top 10 Hldgs %
10.7%
Holding
2,791
New
730
Increased
583
Reduced
470
Closed
679
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$53M |
| 2 |
NextEra Energy
NEE
|
+$52.3M |
| 3 |
CenterPoint Energy
CNP
|
+$42.7M |
| 4 |
NiSource
NI
|
+$38.8M |
| 5 |
Exelon
EXC
|
+$36.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
US Bancorp
USB
|
+$47.9M |
| 2 |
AstraZeneca
AZN
|
+$38.7M |
| 3 |
GFLU
GFL Environmental Inc. Tangible Equity Units
GFLU
|
+$35.7M |
| 4 |
VMW
VMware, Inc
VMW
|
+$32.4M |
| 5 |
PCGU
PG&E Corporation
PCGU
|
+$30.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 12.25% |
| 2 | Industrials | 9.66% |
| 3 | Utilities | 9.48% |
| 4 | Technology | 8.06% |
| 5 | Healthcare | 7.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1276
Upbound Group
UPBD
$1.18B
| $368K | 0.01% |
+15,000
| New | +$386K |
|
1277
General Mills
GIS
$19.2B
| $366K | 0.01% |
4,287
-2,577
| -38% | -$206K |
|
1278
Alkermes
ALKS
$8.31B
| $366K | 0.01% |
12,985
-31,359
| -71% | -$854K |
|
|
LVAC
1279
DELISTED
LAVA Medtech Acquisition Corp. Class A Common Stock
LVAC
| $366K | 0.01% |
35,070
| – | – |
|
1280
Arhaus
ARHS
$1.12B
| $366K | 0.01% |
+44,122
| New | +$533K |
|
1281
Vital Farms
VITL
$548M
| $366K | 0.01% |
+23,906
| New | +$379K |
|
|
IBTX
1282
DELISTED
Independent Bank Group, Inc.
IBTX
| $366K | 0.01% |
+7,888
| New | +$448K |
|
1283
Ingredion
INGR
$6.33B
| $364K | 0.01% |
3,578
+589
| +20% | +$58.8K |
|
1284
SLM Corp
SLM
$5.09B
| $364K | 0.01% |
29,361
+6,966
| +31% | +$103K |
|
1285
UGI
UGI
$7.78B
| $363K | 0.01% |
10,437
+3,602
| +53% | +$137K |
|
1286
PUT
Newmont
NEM
$100B
| $363K | 0.01% |
7,400
| – | – |
|
1287
Element Solutions
ESI
$9.18B
| $361K | 0.01% |
18,684
-6,581
| -26% | -$130K |
|
1288
TSMC
TSM
$2.11T
| $360K | 0.01% |
3,875
-11,495
| -75% | -$1.03M |
|
1289
Broadridge
BR
$18.2B
| $359K | 0.01% |
2,446
+774
| +46% | +$111K |
|
1290
Henry Schein
HSIC
$9.85B
| $357K | ﹤0.01% |
+4,375
| New | +$357K |
|
1291
Genpact
G
$5.96B
| $356K | ﹤0.01% |
+7,705
| New | +$360K |
|
1292
Medpace
MEDP
$16B
| $356K | ﹤0.01% |
+1,892
| New | +$391K |
|
1293
Synaptics
SYNA
$4.13B
| $356K | ﹤0.01% |
3,201
-597
| -16% | -$68.8K |
|
|
NOVA
1294
DELISTED
Sunnova Energy
NOVA
| $356K | ﹤0.01% |
22,776
-17,370
| -43% | -$303K |
|
1295
Nordic American Tanker
NAT
$1.36B
| $355K | ﹤0.01% |
+89,700
| New | +$322K |
|
1296
Thermo Fisher Scientific
TMO
$213B
| $355K | ﹤0.01% |
616
-1,346
| -69% | -$759K |
|
1297
Knowles
KN
$3.2B
| $354K | ﹤0.01% |
+20,819
| New | +$363K |
|
1298
Valaris
VAL
$5.32B
| $353K | ﹤0.01% |
5,433
-1,825
| -25% | -$127K |
|
1299
Archrock
AROC
$6.16B
| $353K | ﹤0.01% |
+36,110
| New | +$354K |
|
1300
CALL
Alphabet (Google) Class A
GOOGL
$4.57T
| $353K | ﹤0.01% |
3,400
-6,700
| -66% | -$643K |
|
Similar funds
RFC
NMO
EH
OAC
UM
EF
Verition Fund Management's Q1 2023 Portfolio in Review
As of Q1 2023, Verition Fund Management held 2,791 positions worth $7.23B, up 13% from $6.4B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Verition Fund Management withdrew a net $307M in Q1 2023, closing 679 positions and reducing 470 holdings. Its most notable exit was AstraZeneca, an estimated $38.7M position sold in full.
By sector, the portfolio is most concentrated in Financials at 12% of assets, down from 13% a quarter earlier, followed by Industrials and Utilities.
Against the trend, Verition Fund Management opened a new position in Jacobs Solutions worth $33.6M.
- Verition Fund Management's largest Q1 2023 buy was Jacobs Solutions: 346,045 shares worth $33.6M.
- Verition Fund Management added most to Horizon Therapeutics Public Limited Company Ordinary Shares in Q1 2023, an estimated $53M increase.
- Verition Fund Management's biggest Q1 2023 reduction was US Bancorp, cutting an estimated $47.9M.
- Verition Fund Management fully exited AstraZeneca in Q1 2023, selling an estimated $38.7M.
- Verition Fund Management's ten largest holdings make up 11% of its $7.23B portfolio in Q1 2023.
- Verition Fund Management opened 730 new positions and closed 679 in Q1 2023.
- Verition Fund Management's portfolio value rose 13% quarter-over-quarter to $7.23B.
Based on Verition Fund Management's 13F filing for Q1 2023, filed 15 May 2023.